(0.25%) 5 321.41 points
(0.17%) 39 873 points
(0.22%) 16 833 points
(-0.25%) $79.06
(-1.35%) $2.64
(-0.01%) $2 425.70
(0.82%) $32.34
(0.38%) $1 064.90
(-0.04%) $0.921
(-0.13%) $10.64
(-0.09%) $0.786
(0.27%) $90.47
Live Chart Being Loaded With Signals
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases...
Stats | |
---|---|
Dagens volum | 953 120 |
Gjennomsnittsvolum | 1.94M |
Markedsverdi | 204.98M |
EPS | $0 ( 2024-05-20 ) |
Neste inntjeningsdato | ( $-0.0500 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.79 |
ATR14 | $0.00500 (0.31%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-10 | Finn Jonathan | Buy | 25 000 | Common Stock |
2024-03-09 | Cigler Tessa | Buy | 20 834 | Stock Option (right to buy) |
2024-03-09 | Cigler Tessa | Buy | 0 | |
2023-11-15 | Weaver Gregory L | Sell | 50 000 | Common Stock |
2023-11-15 | Finn Jonathan | Buy | 62 500 | Stock Option (right to buy) |
INSIDER POWER |
---|
70.89 |
Last 98 transactions |
Buy: 26 594 652 | Sell: 4 017 362 |
Volum Korrelasjon
Atossa Therapeutics Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
GIFI | 0.952 |
LFMDP | 0.948 |
SG | 0.946 |
RPAY | 0.937 |
RGLS | 0.929 |
SWBI | 0.929 |
CPRT | 0.926 |
PUBM | 0.926 |
MNMD | 0.925 |
DXPE | 0.924 |
10 Mest negative korrelasjoner | |
---|---|
RETO | -0.916 |
RGF | -0.911 |
UONEK | -0.909 |
EEIQ | -0.909 |
HRZN | -0.909 |
TCPC | -0.905 |
CLEU | -0.901 |
TTEC | -0.898 |
QNRX | -0.897 |
GAN | -0.897 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Atossa Therapeutics Inc Korrelasjon - Valuta/Råvare
Atossa Therapeutics Inc Økonomi
Annual | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $-23 000.00 (0.00 %) |
EPS: | $-0.240 |
FY | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $-23 000.00 (0.00 %) |
EPS: | $-0.240 |
FY | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $-8 000.00 (0.00 %) |
EPS: | $-0.210 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-0.180 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Atossa Therapeutics Inc
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patients; AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.